You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
AstraZeneca PLC (AZN) - free report >>
Pfizer Inc. (PFE) - free report >>
Moderna, Inc. (MRNA) - free report >>
iShares Russell 2000 ETF (IWM) - free report >>
Small Cap ETFs Deliver Big Gains for Investors
November was a historic month for stocks-- the Dow was up about 11.8% for the month, the S&P 500 rose 10.8% while the Nasdaq gained 11.8%. Unlike earlier this year, when the rally was led mainly by mega-cap tech stocks, economically sensitive areas emerged as the biggest winners last month. The small-cap Russell 2000 index surged about 18.3% -- its best monthly gain ever.
The widening of rally was thanks mainly to very encouraging vaccine trial results from Pfizer (PFE - Free Report) , Moderna (MRNA - Free Report) and AstraZeneca (AZN - Free Report) . Hopes that the presidential transition would be smooth have also boosted investor sentiment. Additionally, nomination of Janet Yellen for Treasury secretary has reignited hopes of a large stimulus next year, which would benefit smaller companies a lot.
To learn more the iShares Russell 2000 ETF (IWM - Free Report) , the iShares Core S&P Small-Cap ETF (IJR - Free Report) and the Vanguard Small Cap Growth ETF (VBK - Free Report) that soared in November, please watch the short video above.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>